Importantly, FGFR4, FGF19 and phospho-AKT were found to be co-overexpressed in a subset of basal-like breast tumors, suggesting that the FGFR4/FGF19 autocrine loop might be of clinical importance. This evidence concerns the gene AKT1 and breast neoplasm.